Work

The GTPase assay as a highly sensitive model system for characterization of human cannabinoid receptors and their ligands. G alpha i2 co-expression and fusion studies and the impact of RGS proteins

Year: 2010
Type: dissertation
Abstract: So far two human cannabinoid receptors (hCBRs) have been identified, both belonging to the family of G protein coupled receptors (GPCRs): the hCB1R mainly located in the brain and the hCB2R predominantly located in the periphery on immune cells. Because of their involvement in many physiological functions, such as movement, metabolic regulation, host defense, analgesia and memory, there is still a great interest for targeting CBRs for therapeutic applications.\nThe aim of this thesis was the establishment of a highly sensitive assay system that is suitable to analyze CBR pharmacology and to screen ligands concerning their CBR activity and their pharmacological profile. Therefore, we established the steady-state [gamma-32P]-GTPase assay, a functional, sensitive and reliable approach to study GPCRs with a read out at a very proximal point of the signal cascade. In native systems, this in-vitro assay showed a very low sensitivity. In rat cerebellum membrane only a weak stimulation of GTPase activity was measurable. The use of membranes of CBR transfected HEK 293 cells did not lead to a successful outcome as no change of GTPase activity caused by a ligand was detectable. These results directed us to employ Spodoptera frugiperda (Sf9) cell membranes as expression system. Here, the co-expression of CBRs, Gα subunit and the G beta-gamma heterodimer greatly improved the sensitivity of the assay. \nAs the efficacy of receptor-G protein interaction is highly influenced by the expression levels and density of these proteins in the membrane, we examined the impact of CBR-Gα fusion proteins on pharmacological properties of known CBR ligands. With the defined 1:1 stoichiometry and the forced anchor of the signaling partners in the membrane, the sensitivity of the GTPase assay was dramatically increased. Influences of regulators of G protein signaling (RGS) proteins RGS4 and RGS19 on GTPase activity in the co-expression and fusion system were examined. The results revealed that RGS4 in contrast to RGS19 behaves as a GTPase activating protein (GAP) for CBRs. \nComparing pharmacological properties of known CBR ligands evaluated in the co-expression and fusion systems in the absence or presence of RGS4 and RGS19, altered potencies and efficacies became apparent, especially in the CB2R test systems. These data suggests that ligands stabilized specific GDP/GTP exchange-promoting receptor conformations that are influenced by the forced contact to the Gαi2 subunit and the addition of RGS protein. This phenomenon is indicative for the concept of ligand-specific receptor conformation.\nFor ligand screening procedures and to evaluate pharmacological parameters of new CBRs ligands, we used Sf9 cell membranes expressing CBR-Gα fusion proteins, the G beta-gamma-heterodimer and RGS4 as this constellation offers the highest sensitivity among the tested protein combinations. We examined various alkamides, polyacetylenes and polyenes isolated from Echinacea species as well as synthesized indole derivatives. From the natural compounds several alkamides showed measurable activity in a CB2R selective manner. In contrast to the alkamides, polyacetylenes and polyenes did not show any effect, suggesting that they do not exert their immunomodulatory effect via the CBRs. Furthermore, new \n2,3-disubstituted indole derivatives with activity at the CB2R were found. Thereby, the 3-(2-butylindole-3-yl)prop-2-en acid ethyl ester showed the strongest effect and provides a promising basis for the development of potent and selective CB2R ligands.
Author: Sarah Sutor
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W69608419
Cites: 170
Cited by: 1
Related to: 9